SEC Filing Details

Document Details

Form
Filing Date
Jul 17, 2018
Document Date
Jul 13, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aeglea Biotherapeutics, Inc.
Issuer
Aeglea BioTherapeutics, Inc.
Filer
LAWLIS V BRYAN